Effects of Myofascial Release and TENS Over Pain, Hand Prehensile Strength and Functionality of Superior Extremity in Women With Lateral Epicondylalgia

NCT ID: NCT04023279

Last Updated: 2019-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-24

Study Completion Date

2018-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluated the additive effect of myofascial release therapy on the brachial biceps on conventional management (TENS) in pain intensity, hand prehensile strength and upper limb functionality of individuals with lateral epicondylalgia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study determined the additive effect of the myofascial release therapy of brachial biceps on TENS in the variables pain intensity, hand prehensile strength and upper limb functionality of individuals with lateral epicondylalgia, compared to a group that received only TENS. This was done in a sample of 32 individuals, assigned in two groups: group A that received an application of TENS and group B that received an application of TENS plus myofascial release therapy.

Contrary to the hypothesis, the application of myofascial release therapy added to the application of TENS proved to generate a significant change only in the prehensile hand force with respect to the group that received only TENS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Manipulations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Quantitative, experimental prospective, explanatory type, randomized controlled parallel with simple blind.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
The hidden assignment of the participants was carried out using the method of opaque envelopes sealed and numbered consecutively.

The assessor in charge of evaluating the participants was blind to the treatment assignment, where he proceeded to take the measurements with a prior instruction of the procedures.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TENS

Conventional TENS of 100 Hz and 100 usec for 20 minutes

Group Type EXPERIMENTAL

TENS

Intervention Type OTHER

100 Hz and 100 usec for 20 minutes

Myofascial Therapy

Conventional TENS of 100 Hz and 100 usec for 20 minutes plus myofascial release therapy in the brachial biceps; Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding

Group Type EXPERIMENTAL

TENS

Intervention Type OTHER

100 Hz and 100 usec for 20 minutes

Myofascial therapy

Intervention Type OTHER

Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding of myofascial release therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TENS

100 Hz and 100 usec for 20 minutes

Intervention Type OTHER

Myofascial therapy

Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding of myofascial release therapy

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Transcutaneous electrical nerve stimulation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female between 30 and 50 years old.
* Belong to the administrative staff of the university in question
* Have a symptomatic diagnosis of chronic lateral epicondylitis (\> 6 weeks)

Exclusion Criteria

* Being pregnant
* Have done moderate or intense aerobic or anaerobic sport activities of any kind 72 hours before the registrations
* Have an orthopedic, rheumatologic, neuropsychiatric or associated comorbidities diagnosed.
* Have suffered a fracture or trauma involving the upper extremity 4 months before the intervention.
* Be in medical, pharmacological or kinesthetic treatment during the intervention or 2 weeks before this.
Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fernanda Merino Alvarez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fernanda Merino Alvarez

Sponsor and Principal Investigator Fernanda Merino Alvarez

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jorge Fuentes, PhD

Role: STUDY_DIRECTOR

Universidad Andres Bello

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad Andres Bello

Talcahuano, Concepción, Chile

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UniversidadNAB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.